Michael Braun
InvestorVenture Partner at 415 Capital
Germany
Writes $100K – $5M checks · typically $1.5M
About
Michael Braun is a biomedical engineer and inventor who holds several medical device patents and serves as Senior Venture Partner at 415C, where he focuses on technical evaluation of prospective portfolio companies. He is CEO of Symedrix GmbH and was CEO of CoRRect Medical GmbH, which he co-founded in 2010 and which was acquired by Uniphar PLC in 2021. He previously co-founded Reverse Medical Corp. (acquired by Covidien in 2015), held roles at Medtronic, and began his career in R&D at Rüsch AG / Teleflex, where he invented the Polyflex stent. He holds a B.Sc. in Biomedical Engineering from the University of Aachen, Germany.
Invests in
Medical Devices
Experience
- 415 CAPITALSenior Venture Partnercurrent2019 — presentGreater Munich Metropolitan Area
- Symedrix GmbHCEOcurrent2015 — presentMunich, Bavaria, Germany
- Correct Medical GmbHCEO2009 — 2025München
Skills & more
+9 more
Capital EquipmentInterventional RadiologyInterventional CardiologyProduct LaunchVascular SurgeryCross-functional Team LeadershipCommercializationSurgeryBusiness DevelopmentLanguages English · German
From Michael's professional profile.
Shared employers
Also worked at Correct Medical GmbH1
Colleagues at 415 Capital
Network4
Investors connected to Michael in public investor directories — a warm-intro map.